Answers are grounded in this paper and cite their sources.
Despite the high frequency of TP53 mutations across cancers, how its loss promotes clonal expansion is not fully understood. Gan and colleagues integrated transcriptomic, chromatin immunoprecipitation (ChIP) sequencing, and genetic screen data to uncover this link. To distinguish between canonical and other effects, a Trp533KR/3KR mouse epidermis model unable to activate canonical cell cycle arrest, cell death, or senescence was utilized. In comparing Trp533KR/3KR with p53 loss (Trp53–/–) and wild type (WT), only Trp53–/– demonstrated basal cell expansion and increased renewal, suggesting that canonical functions are not necessary to restrict clonal expansion. To determine transcriptional targets of p53 that may regulate renewal and differentiation, RNA, ChIP, and assay for transposase-accessible chromatin with high-throughput (ATAC) sequencing data were integrated, highlighting candidates present in both WT and Trp533KR/3KR progenitors. To further narrow down potential regulators, a short hairpin RNA (shRNA)-based in vivo screen was conducted. Top hits were selected by measuring their ability to promote renewal or differentiation and assigning scores based on synergistic effects, identifying three p53 transactivated genes: secreted frizzled-related protein 1 (Sfrp1), low-density lipoprotein receptor-related protein 1 (Lrp1), and ubiquitin-specific peptidase 22 (Usp22). Depletion of these genes led to increased Wnt activity, consistent with known roles for Sfrp1 and Lrp1 as Wnt suppressors, while their overexpression in the context of p53 loss had the reverse effect. Sfrp1, Lrp1, and Usp22 reduce Wnt signaling at the ligand, receptor, and nuclear level, respectively, suggesting multilevel control of the Wnt network. Thus, Wnt activity was measured in relation to the distance between Trp53–/– and WT clones, capturing a gradient of activity and renewal rate that increased from the edges to the center Trp53–/–clones. Furthermore, it was found that the Wnt activity gradient, rather than its amplitude, strongly influenced clonal expansion. Taken together, this study identifies Sfrp1, Lrp1, and Usp22 as p53-driven suppressors of Wnt signaling; disruption of this regulatory network by p53 loss leads to spatially dependent progenitor cell renewal.Gan Q, Li W, Lex RK, Ying Z, Beronja S. Loss of the tumor suppressor p53 generates a signaling gradient that drives epithelial clonal expansion. Science 2026;394:eaed3065.Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at https://aacrjournals.org/cdnews.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: